A critical analysis of the reform of the pharmaceutical sector in Iran, with specific reference to the regulatory framework

This thesis examines the theoretical and empirical case for reform of Iran’s pharmaceutical sector. It supports the view that a private pharmaceutical sector in Iran is not, necessarily, more accountable or effective than the public pharmaceutical sector. The thesis, therefore, argues that mass privatisation implemented in economic isolation cannot deliver the much-needed panacea for the pharmaceutical industry’s woes in Iran. This research recommends applying a combination of the old government-planned system and modern market-oriented forces, which can be achieved by adopting responsive pharmaceutical regulations and increasing the participation of non-governmental actors.